| T‐cell receptor binding affinities and kinetics: impact on T‐cell activity and specificity JD Stone, AS Chervin, DM Kranz Immunology 126 (2), 165-176, 2009 | 475 | 2009 |
| Postsynaptic scaffolds of excitatory and inhibitory synapses in hippocampal neurons: maintenance of core components independent of actin filaments and microtubules DW Allison, AS Chervin, VI Gelfand, AM Craig Journal of Neuroscience 20 (12), 4545-4554, 2000 | 314 | 2000 |
| Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor J An, AS Chervin, A Nie, HS Ducoff, Z Huang Oncogene 26 (5), 652-661, 2007 | 130 | 2007 |
| The impact of TCR-binding properties and antigen presentation format on T cell responsiveness AS Chervin, JD Stone, PD Holler, A Bai, J Chen, HN Eisen, DM Kranz The Journal of Immunology 183 (2), 1166-1178, 2009 | 107 | 2009 |
| Engineering higher affinity T cell receptors using a T cell display system AS Chervin, DH Aggen, JM Raseman, DM Kranz Journal of immunological methods 339 (2), 175-184, 2008 | 96 | 2008 |
| Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains DH Aggen, AS Chervin, TM Schmitt, B Engels, JD Stone, SA Richman, ... Gene therapy 19 (4), 365-374, 2012 | 76 | 2012 |
| Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors DH Aggen, AS Chervin, FK Insaidoo, KH Piepenbrink, BM Baker, ... Protein Engineering, Design & Selection 24 (4), 361-372, 2011 | 62 | 2011 |
| Long-term persistence of CD4+ but rapid disappearance of CD8+ T cells expressing an MHC class I-restricted TCR of nanomolar affinity B Engels, AS Chervin, AJ Sant, DM Kranz, H Schreiber Molecular Therapy 20 (3), 652-660, 2012 | 56 | 2012 |
| T cell receptor engineering JD Stone, AS Chervin, DH Aggen, DM Kranz Methods in enzymology 503, 189-222, 2012 | 52 | 2012 |
| A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control JD Stone, DT Harris, CM Soto, AS Chervin, DH Aggen, EJ Roy, DM Kranz Cancer immunology, immunotherapy 63, 1163-1176, 2014 | 46 | 2014 |
| Interaction of streptavidin-based peptide–MHC oligomers (tetramers) with cell-surface TCRs JD Stone, MN Artyomov, AS Chervin, AK Chakraborty, HN Eisen, ... The Journal of Immunology 187 (12), 6281-6290, 2011 | 40 | 2011 |
| MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR CM Soto, JD Stone, AS Chervin, B Engels, H Schreiber, EJ Roy, ... Cancer Immunology, Immunotherapy 62, 359-369, 2013 | 39 | 2013 |
| Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses AS Chervin, JD Stone, CM Soto, B Engels, H Schreiber, EJ Roy, ... Gene therapy 20 (6), 634-644, 2013 | 37 | 2013 |
| Opposite effects of endogenous peptide–MHC class I on T cell activity in the presence and absence of CD8 JD Stone, DH Aggen, AS Chervin, S Narayanan, TM Schmitt, ... The Journal of Immunology 186 (9), 5193-5200, 2011 | 22 | 2011 |
| Cutting edge: inhibitory effects of CD4 and CD8 on T cell activation induced by high-affinity noncognate ligands AS Chervin, JD Stone, NA Bowerman, DM Kranz The Journal of Immunology 183 (12), 7639-7643, 2009 | 17 | 2009 |
| Oligomerization of BH4-truncated Bcl-xL in solution Y Wang, R Cao, D Liu, A Chervin, J Yuan, J An, Z Huang Biochemical and biophysical research communications 361 (4), 1006-1011, 2007 | 14 | 2007 |
| Design and characterization of a protein superagonist of IL‐15 fused with IL‐15Rα and a high‐affinity T cell receptor JD Stone, AS Chervin, H Schreiber, DM Kranz Biotechnology progress 28 (6), 1588-1597, 2012 | 13 | 2012 |
| A Multiplex assay for detection of staphylococcal and streptococcal exotoxins P Sharma, N Wang, AS Chervin, CL Quinn, JD Stone, DM Kranz Plos one 10 (8), e0135986, 2015 | 8 | 2015 |
| Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses DM Mattis, AS Chervin, DR Ranoa, SL Kelley, RI Tapping, DM Kranz Molecular immunology 68 (2), 203-212, 2015 | 3 | 2015 |
| Evaluation of epcoritamab and rituximab combination in preclinical models of B-cell non-Hodgkin's lymphoma (NHL) PK Epling-Burnette, DB Dandamudi, IM Konieczna, KM Calabrese, ... Blood 140 (Supplement 1), 9283-9285, 2022 | 1 | 2022 |
